NewTimeSpace News: YANKUANG ENERGY (01171.HK) announced on 14 July 2026 that it expects net profit attributable to owners of the Company for the six months ended 30 June 2026 to reach approximately RMB7.2 billion, compared with RMB4.7 billion recorded in the same period last year. The expected non-recurring profit and loss-adjusted net profit attributable to shareholders stands at roughly RMB4.5 billion.
InSilico Medicine announced on July 15 that it has entered into a multi-faceted strategic alliance with Bora Pharmaceuticals to integrate InSilico Medicine's Pharma.AI platform with Bora's global drug development, manufacturing and commercialization capabilities. Specific cooperation details are subject to definitive agreements, and if fully implemented, the potential value of the proposed collaboration is expected to exceed US$2.5 billion.
CARsgen Therapeutics announced on July 15 that preliminary positive results of the CT041-CG4010 IIT trial for postoperative adjuvant consolidation therapy for G/GEJA have been accepted for poster presentation at the 2026 ESMO Congress, with the abstract to be published on October 19. Since enrollment began in May 2025, no participants have experienced postoperative recurrence or metastasis. Satri-cel was approved in June 2026 as the world's first solid tumor CAR-T cell therapy product.
361 Degrees voluntarily disclosed its Q2 2026 operating data on July 15, with both the main brand and kids wear brand offline channels recording mid-to-high single-digit positive growth in retail sales, and the e-commerce platform overall GMV recording high single-digit positive growth.
GenFleet Therapeutics entered into a placing agreement on July 14 with Morgan Stanley and CITIC CLSA to place 13.6 million new H-shares at HK$34.69 per share (approximately 9.71% discount to the closing price of HK$38.42), representing approximately 3.67% of the total issued shares, with estimated net proceeds of approximately HK$466.9 million. Approximately 75% of the net proceeds will be used for the core RAS pipeline (GFH276 40%, GFS202A 25%, preclinical IND applications 10%), 15% for R&D technology platform upgrades, and 10% for working capital. The Placing is not subject to shareholders' approval. The closing date is July 17, 2026, and the Company has committed to a 90-day lock-up period post-closing.
Beijing Enterprises Holdings signed a new three-year Financial Services Agreement with the finance company on July 14, effective from August 28, 2026 to August 27, 2029, with an annual cap of RMB12.5 billion for deposit services. The agreement constitutes a continuing connected transaction and major transaction, requiring an EGM for independent shareholders' approval, with Beijing Enterprises Group and its close associates abstaining from voting. Loan services and other financial services are fully exempt.
Juhe Data's wholly-owned subsidiary Juhe Tianqing signed an EPC contract on July 14 with the contractor to build the Public Security Large Model and Report Robot Production Headquarters in Suzhou for approximately RMB101.87 million (tax-inclusive), with a total construction area of approximately 28,351.3 square meters, an expected construction period of 460 days, and a planned completion date of October 28, 2027. The transaction constitutes a discloseable transaction exempt from shareholders' approval.
SF Intra-city announced on July 14 that its controlling shareholder SF Tyson plans to convert approximately 171.76 million domestic shares (representing 18.72% of issued share capital) into H-shares. The Company has submitted an application to the CSRC, but the filing procedures are not yet completed and implementation plan details remain undetermined. SF Tyson and SF Holding currently have no reduction plans.
WEICHAI POWER(02338.HK) will spend CNY 107.3 million to repurchase 21.92 million shares on Jul 14, 2026 .
NewTimeSpace News: Estun announced on 14 July that it expects net profit attributable to parent shareholders for the first half of 2026 to range from RMB 150 million to RMB 180 million, representing a year-on-year increase of 2,144.74% to 2,593.68%.
NewTimeSpace News: CHINA DEVELOPMENT BANK FINANCIAL LEASINGannounced on 14 July that three wholly-owned subsidiaries of the Company entered into shipbuilding contract assignment agreements with the original buyer and the seller to acquire three multi-purpose bulk carriers, with a total consideration capped at USD 138 million.
NewTimeSpace News: Holly Futuresannounced on 14 July that Mr. Zhang Hongfa, Independent Director of the Company, resigned from his posts as Independent Director of the 5th Board of Directors, Chairman of the Nomination Committee, and member of the Risk Management Committee, Remuneration Committee and Strategy & ESG Committee due to personal reasons.
NewTimeSpace News: Shenwan Hongyuan announced on 14 July that its subsidiary Shenwan Hongyuan Securities has received an official approval from the China Securities Regulatory Commission (CSRC), which greenlights its registration application for public offering of perpetual subordinated bonds to professional investors with an aggregate face value not exceeding RMB 30 billion.
NewTimeSpace News: Luxxu Groupannounced on 14 July that Mr. Yang Xi, Executive Director, has resigned from his positions as Executive Director, member of the Remuneration Committee and Authorised Representative due to personal career development and other official commitments, with effect from 14 July.
NewTimeSpace News: United Laboratories announced on 14 July that sodium hyaluronate eye drops (specification: 0.3%, 5ml:15mg) submitted by Zhongshan Branch of Zhuhai United Laboratories, its wholly-owned subsidiary, has passed the drug registration review and approval of the National Medical Products Administration and been granted marketing authorization.
NewTimeSpace News: Dongjiang Environmental announced on 14 July that it expects a net loss attributable to shareholders of the listed company of approximately RMB 250 million to RMB 270 million for the first half of 2026, representing a loss reduction of roughly 2.94% to 10.13% compared with the loss of RMB 278 million recorded in the same period last year.
